This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

ACHM-B3

Applied Genetic Technologies Corporation

Drug Names(s): ACHM, rAAV-CNGB3

Description: rAAV-CNGB3 is an adeno-associated virus (AAV)-based gene therapy targeting the gene for CNGB3, a cyclic nucleotide-gated ion channel responsible for achromatopsia.


ACHM-B3 News


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug